These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 7770009)

  • 1. Mycoplasma-mediated bone resorption in bone organ cultures.
    Novak JF; Hayes JD; McMaster JH
    Microbios; 1995; 81(329):241-60. PubMed ID: 7770009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of calcitonin gene-related peptide on bone resorption mediated by interleukin-1.
    Zhang WZ; Yu SF; Zheng LF
    Chin Med J (Engl); 1994 May; 107(5):351-4. PubMed ID: 7924575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of three murine macrophage populations to particulate debris: bone resorption in organ cultures.
    Glant TT; Jacobs JJ
    J Orthop Res; 1994 Sep; 12(5):720-31. PubMed ID: 7931789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of MALP-2, a lipopeptide from Mycoplasma fermentans, on bone resorption in vitro.
    Piec G; Mirkovitch J; Palacio S; Mühlradt PF; Felix R
    Infect Immun; 1999 Dec; 67(12):6281-5. PubMed ID: 10569738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of calcitonin and indomethacin on bone resorption mediated by interleukin-1].
    Zhang WZ; Yu SF; Zheng LF
    Zhonghua Yi Xue Za Zhi; 1994 Sep; 74(9):530-2, 581-2. PubMed ID: 7842348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclasts.
    Woo JT; Kawatani M; Kato M; Shinki T; Yonezawa T; Kanoh N; Nakagawa H; Takami M; Lee KH; Stern PH; Nagai K; Osada H
    Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4729-34. PubMed ID: 16537392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption.
    Löwik CW; Nibbering PH; van de Ruit M; Papapoulos SE
    J Clin Invest; 1994 Apr; 93(4):1465-72. PubMed ID: 8163651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia is a major stimulator of osteoclast formation and bone resorption.
    Arnett TR; Gibbons DC; Utting JC; Orriss IR; Hoebertz A; Rosendaal M; Meghji S
    J Cell Physiol; 2003 Jul; 196(1):2-8. PubMed ID: 12767036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyethylene and methyl methacrylate particle-stimulated inflammatory tissue and macrophages up-regulate bone resorption in a murine neonatal calvaria in vitro organ system.
    Ren W; Wu B; Mayton L; Wooley PH
    J Orthop Res; 2002 Sep; 20(5):1031-7. PubMed ID: 12382970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of electromagnetic stimulation on the functional responsiveness of isolated rat osteoclasts.
    Shankar VS; Simon BJ; Bax CM; Pazianas M; Moonga BS; Adebanjo OA; Zaidi M
    J Cell Physiol; 1998 Sep; 176(3):537-44. PubMed ID: 9699506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A reappraisal of the effect of extracellular calcium on osteoclastic bone resorption.
    Hall TJ
    Biochem Biophys Res Commun; 1994 Jul; 202(1):456-62. PubMed ID: 8037747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoclast activation: potent inhibition by the bisphosphonate alendronate through a nonresorptive mechanism.
    Owens JM; Fuller K; Chambers TJ
    J Cell Physiol; 1997 Jul; 172(1):79-86. PubMed ID: 9207928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone resorbing activity of surface-associated material from Actinobacillus actinomycetemcomitans and Eikenella corrodens.
    Meghji S; Wilson M; Barber P; Henderson B
    J Med Microbiol; 1994 Sep; 41(3):197-203. PubMed ID: 8064840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relative contribution of cysteine proteinases and matrix metalloproteinases to the resorption process in osteoclasts derived from long bone and scapula.
    Shorey S; Heersche JN; Manolson MF
    Bone; 2004 Oct; 35(4):909-17. PubMed ID: 15454098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activators are involved in the degradation of bone by osteoclasts.
    Everts V; Daci E; Tigchelaar-Gutter W; Hoeben KA; Torrekens S; Carmeliet G; Beertsen W
    Bone; 2008 Nov; 43(5):915-20. PubMed ID: 18691680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective Fas ligand-mediated apoptosis predisposes to development of a chronic erosive arthritis subsequent to Mycoplasma pulmonis infection.
    Hsu HC; Zhang HG; Song GG; Xie J; Liu D; Yang PA; Fleck M; Wintersberger W; Zhou T; Edwards CK; Mountz JD
    Arthritis Rheum; 2001 Sep; 44(9):2146-59. PubMed ID: 11592380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Family 2 cystatins inhibit osteoclast-mediated bone resorption in calvarial bone explants.
    Brand HS; Lerner UH; Grubb A; Beertsen W; Nieuw Amerongen AV; Everts V
    Bone; 2004 Sep; 35(3):689-96. PubMed ID: 15336605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients.
    Grassi F; Cristino S; Toneguzzi S; Piacentini A; Facchini A; Lisignoli G
    J Cell Physiol; 2004 May; 199(2):244-51. PubMed ID: 15040007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
    Kneissel M; Luong-Nguyen NH; Baptist M; Cortesi R; Zumstein-Mecker S; Kossida S; O'Reilly T; Lane H; Susa M
    Bone; 2004 Nov; 35(5):1144-56. PubMed ID: 15542040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoclasts are capable of particle phagocytosis and bone resorption.
    Wang W; Ferguson DJ; Quinn JM; Simpson AH; Athanasou NA
    J Pathol; 1997 May; 182(1):92-8. PubMed ID: 9227347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.